Journal of Cardiology & Cardiovascular Surgery scientific, open-access, double-blind peer-reviewed journal covering a wide spectrum of topics in cardiology and cardiovascular surgery. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Original Article
The relationship between the ABO blood group and chronic venous disease in deep vein thrombosis
Aims: This study aims to investigate the relationship between the ABO blood group and chronic venous disease in terms of deep vein thrombosis (DVT).
Methods: This study was planned as a retrospective case-control study in which 1031 patients were included between February 1, 2022, and July 1, 2022. After systematic sampling, the case group (88) and the control group (113) were analyzed in terms of blood groups. Then the patients were divided into 3 groups. group 1: patients with non-O blood group and chronic venous disease (CVD) (n=75), group 2: patients with non-O blood group and non-CVD (n=73), and group 3: patients with O blood group and CVD patients (n=28). It was analyzed whether there was a difference between these 3 groups and from which group and in what form.
Results: The non-O blood group was significantly higher in the DVT group than the control group (p=0.001). There was no significant difference between A, B, and AB blood groups (p=0,21, p=0,51, p=0,08, respectively). When group 1, group 2, and group 3 were compared, a significant difference was found (p=0,006). In the posthoc analysis, no difference was found between group 1 and group 2 (p=0.99), a difference was found between group 3 and group 1 - group 2, and it was found to be lower (p=0.34, p=0.46, respectively).
Conclusion: We found the non-O blood group was higher in the DVT group compared to the control group. We found that the non-O blood group alone was higher in patients with DVT than CVD alone. While non-O blood type and CVD are important risk factors for DVT, non-O blood type can increase the risk of DVT more than CVD. However, this finding needs to be discussed in future studies.

1. Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism.Lancet. 2021;398(10294):64-77.
2. Anderson Jr FA, Spencer FA. Risk factors for venous thromboembolism.Circulation. 2003;107(23 Suppl 1):I9-I16.
3. Franchini M, Mannucci PM. ABO blood group and thromboticvascular disease. Thromb Haemost. 2014;112(6):1103-1109.
4. Li R, Chen Z, Gui L, et al. Varicose veins and risk of venousthromboembolic diseases: a two-sample-based mendelianrandomization study. Front Cardiovasc Med. 2022;9:849027.
5. Spiezia L, Campello E, Bon M, et al. ABO blood groups and the riskof venous thrombosis in patients with inherited thrombophilia. BloodTransfus. 2013;11(2):250-253.
6. Spavor M, Halton J, Dietrich K, et al. Age at cancer diagnosis, non-Oblood group and asparaginase therapy are independently associatedwith deep venous thrombosis in pediatric oncology patients: a riskmodel. Thromb Res. 2016;144:27-31.
7. Schleef M, Strobel E, Dick A, Frank J, Schramm W, Spannagl M.Relationship between ABO and Secretor genotype with plasma levelsof factor VIII and von Willebrand factor in thrombosis patients andcontrol individuals. Br J Haematol. 2005;128(1):100-107.
8. Martinelli I. von Willebrand factor and factor VIII as risk factors forarterial and venous thrombosis. Semin Hematol. 2005;42(1):49-55.
9. Larsen TB, Johnsen SP, Gislum M, Moller CA, Larsen H, SorensenHT. ABO blood groups and risk of venous thromboembolism duringpregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost. 2005;3(2):300-304.
10. Jukic I, Bingulac-Popovic J, Dogic V, et al. ABO blood groups andgenetic risk factors for thrombosis in Croatian population. Croat MedJ. 2009;50(6):550-558.
11. Dentali F, Di Minno MN, Turato S, et al. Role of ABO blood group andof other risk factors on the presence of residual vein obstruction afterdeep-vein thrombosis. Thromb Res. 2014;134(2):264-267.
12. Cai C, Guo Y, You Y, et al. Deep venous thrombosis inCOVID-19 patients: a cohort analysis. clin appl thromb hemost.2020;26:1076029620982669.
13. Günertem E, Akay T, Aliyev A, et al. Treatment and prophylaxisstrategies for deep vein thrombosis during COVID-19 outbreak. Turk JVasc Surg. 2020;29(3):203-207.
Volume 2, Issue 1, 2024
Page : 1-5